Benign Prostate Hyperplasia. Benign neoplasm of prostate
Conditions
Interventions
Intervention 1: Intervention group: They will take one ginseng capsule every 12 hours and one tamsulosin capsule 0.4 mg daily before bedtime. Intervention 2: Intervention group: They will take one lic
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
50 Years to 70 Years
Inclusion criteria
Inclusion criteria: IPSS = 8 PSA 30 cc
Exclusion criteria
Exclusion criteria: History of treatment with anticholinergic drugs in the past month Having a urinary tract infection History of prostate surgery Having neurological disorders such as Parkinson's or stroke
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in urinary symptoms. Timepoint: Before treatment and 3 months after treatment. Method of measurement: IPSS Urinary Function Questionnaire.;Changes in patients' sexual function. Timepoint: Before treatment and 3 months after treatment. Method of measurement: With the IIEF sexual function questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence of drug side effects. Timepoint: From the start of treatment to the end of treatment. Method of measurement: Clinical examination and questioning of patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbbas Moradi
Hamedan University of Medical Sciences
Outcome results
None listed